Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Malaria vaccine (FMP012) - Walter Reed Army Institute of Research/US Army Medical Research and Materiel Command

Next Previous
Drug Profile

Malaria vaccine (FMP012) - Walter Reed Army Institute of Research/US Army Medical Research and Materiel Command

Alternative Names: Falciparum malaria protein-12 vaccine; FMP012; FMP012 subunit malaria vaccine - WRAIR; FMP012/AS01B malaria vaccine; Malaria vaccine PfCelTOS WRAIR; Malaria vaccine recombinant FMP012; Plasmodium falciparum FMP012 vaccine; Plasmodium falciparum PfCelTOS vaccine; Plasmodium falciparum vaccine FMP012; Recombinant FMP012 malaria vaccine

Latest Information Update: 16 Aug 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator United States Army Medical Research and Materiel Command; Walter Reed Army Institute of Research
  • Class Antimalarials; Parasitic vaccines; Subunit vaccines; Synthetic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Malaria

Most Recent Events

  • 28 Jul 2018 No recent reports of development identified for phase-I development in Malaria(Prevention, In volunteers) in USA (IM, Injection)
  • 11 Jun 2014 Preclinical trials in Malaria (Prevention) in USA (IM)
  • 11 Jun 2014 Walter Reed Army Institute of Research and US Army Medical Research and Materiel Command plan a phase I trial for Malaria (Prevention) in USA (NCT02174978)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top